NeueHealth (NYSE:NEUE) Releases Quarterly Earnings Results, Misses Expectations By $5.12 EPS

NeueHealth (NYSE:NEUE) issued its quarterly earnings data on Thursday. The company reported ($7.41) earnings per share for the quarter, missing the consensus estimate of ($2.29) by ($5.12), Zacks reports. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%.

NeueHealth Stock Performance

Shares of NYSE NEUE traded up $0.45 during trading on Thursday, hitting $5.29. 10,345 shares of the company traded hands, compared to its average volume of 19,330. NeueHealth has a fifty-two week low of $3.79 and a fifty-two week high of $7.66. The firm has a market capitalization of $43.79 million, a price-to-earnings ratio of -0.10 and a beta of 0.56. The business’s fifty day moving average is $7.11 and its 200 day moving average is $6.00.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada dropped their target price on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Monday, December 9th.

Insider Buying and Selling

In related news, CEO George Lawrence Mikan III sold 12,440 shares of the company’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the sale, the chief executive officer now owns 249,454 shares in the company, valued at $1,529,153.02. This represents a 4.75 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jay Matushak sold 4,970 shares of the company’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the sale, the chief financial officer now owns 17,747 shares in the company, valued at $130,085.51. This represents a 21.88 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 110,033 shares of company stock worth $774,560 in the last quarter. Insiders own 64.30% of the company’s stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.